← Leaderboards
Anna Podolanczuk
Columbia University Health Sciences
$858,060
Attributed
$858,060
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $171.6K · FY2018–22$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$858,060 · 1
By mechanism
K23$858,060 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Alan Richard Tall$42,229,886
- Henry N Ginsberg$119,772,603
- R Graham Barr$40,525,821
- Richard Mayeux$113,943,785
- Davangere P Devanand$43,591,695
Others in their field
Other Emerging Leaders on “Clinical Investigator”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Beth Baseler · Leidos Biomedical Research, Inc.$85,422,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$80,084,822
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
Research focus
Clinical InvestigatorClinical EpidemiologyAffectAncillary StudyAnimal ModelAdultAntioxidantsApolipoprotein A-IApolipoprotein A-IiApolipoproteins AAreaAttenuatedAttenuationAwardBiological MarkersBiologyBiometryBlood VesselsCareerCareer DevelopmentChestCholesterolClinical DiagnosisCommunities
Grant awards (5)
Role of High Density Lipoproteins in Interstitial Lung Disease$171,612
K23 · FY2022 · HL · contact PI
Role of High Density Lipoproteins in Interstitial Lung Disease$171,612
K23 · FY2021 · HL · contact PI
Role of High Density Lipoproteins in Interstitial Lung Disease$171,612
K23 · FY2020 · HL · contact PI
Role of High Density Lipoproteins in Interstitial Lung Disease$171,612
K23 · FY2019 · HL · contact PI
Role of High Density Lipoproteins in Interstitial Lung Disease$171,612
K23 · FY2018 · HL · contact PI